However, DOE treatment at two concentrations could reverse the effect of muscle atrophy induced by a CT26 tumor through a reduced expression level of Atrogin1 and an increased expression level of MYH2 compared with CT26-bearing mice, which received diluent only (Figure 2E). The gene discussed is DDX53; the disease is neoplasm.